ClinicalTrials.gov
public full text
Public Domain
Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder
Summary of Study Protocol. This project is designed to test neurobehavioral mechanisms underlying effects of the dual orexin-1/2 receptor antagonist suvorexant on sleep efficiency and opioid abstinence, and whether these outcomes are independent of one another. This will be the first study to investigate whether suvorexant improves outpatient opioid abstinence and sleep efficiency; and whether improving sleep mediates the improved opioid abstinence outcome. 120 participants with opioid use disorder (OUD) will complete this intent-to-treat study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder#843855
- The Effect of Light Intervention on Recovery in Individuals With Opioid Use Disorder (OUD)#1195769
- Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder#834294
- Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance#838510
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3#994775
Record · ID 1351809
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive